This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Koç Üniversitesi, Orta Dogu Tekník Üníversítesí. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: Gizem Atakan: Innovator in Photodynamic Therapy
Introduction
Gizem Atakan is a prominent inventor based in Ankara, Turkey. She has made significant contributions to the field of photodynamic therapy, particularly in the development of near-infrared (NIR) absorbing photosensitizers. Her innovative work aims to enhance cancer treatment methods, making them more accessible and less invasive.
Latest Patents
Gizem Atakan holds 1 patent for her invention of near-infrared (NIR) absorbing photosensitizers. These photosensitizers are designed for imaging and treatment of cancer in photodynamic therapy (PDT). They are specifically targeted to mitochondria and are water-soluble, functioning as a cytotoxic drug in cancer treatment. The NIR photosensitizers are activated by wavelengths of light that penetrate through the body, not just the skin. This innovation seeks to transform PDT from a specialized treatment into a generally applicable one, offering a nearly non-invasive alternative to current treatment methods.
Career Highlights
Throughout her career, Gizem Atakan has worked with esteemed institutions such as Orta Doğu Teknik Üniversitesi and Koç Üniversitesi. Her research and development efforts have positioned her as a key figure in the advancement of cancer therapies.
Collaborations
Gizem has collaborated with notable colleagues, including Toghrul Almammadov and Safacan Kolemen. These partnerships have further enriched her research and contributed to her innovative projects.
Conclusion
Gizem Atakan's work in developing near-infrared absorbing photosensitizers represents a significant advancement in cancer treatment. Her contributions are paving the way for more effective and less invasive therapies, showcasing her dedication to improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile